Infectious Disease Resources
Videos
Watch L.J. Tan, MS, PhD, & Maria Woosley, DNP, APRN CPNP-AC discuss the different types of immunizations currently available, as well as those under review by FDA, policies impacting access to RSV immunizations and the real-world impact of RSV on infants, children and families.
To boost public health and maximize disease prevention, all immunizations should be treated the same.
This survey briefing discusses the indirect impact and burden of RSV on babies, young children, their families and the health care providers who treat young RSV patients. Two surveys were conducted, one of parents who had at least one child contract RSV, and one of pediatric health care providers who treat babies and young children with RSV.
General pediatrician Lynn Smitherman, MD, explains how the burden of RSV weighs heavily on babies, children and their families.
All mothers want what's best for their babies. Through greater awareness, heightened vigilance and approved testing, babies have a better chance of healthy growth and development before birth.
Infants need health care tailored to their age, weight and medical condition. But that's not always what they receive.
Hepatitis C isn’t only a baby boomer problem anymore. Spurred by the opioid epidemic and a national spike in heroin use, the disease also threatens young people -- including women of childbearing age.
Papers
When hospital procurement decisions are focused on cost, patients pay the price.
When a baby receives harmful antibodies, what happens?
A number of different diseases can develop.
Why is it important that medications and devices be developed specifically
for infants?
When it comes to medical innovation, not all patients are the same.
Blogs
Children and infants should be tested for hepatitis C if they may have been exposed at or around birth, according to new recommendations from the Centers for Disease Control and Prevention.
A CDC advisory committee’s recent discussion about childhood immunizations could impact which new vaccines are available to which children.
The youngest and most vulnerable victims of America’s expanding hepatitis C epidemic are newborn babies. Yet many of those exposed to the virus aren’t getting tested.
No parent wants to see their child wince in pain or hear their baby cry. Yet enduring the undesirable for just a minute – as the child is vaccinated – can save heartache down the road.
Infants and children may soon have another line of protection against potentially life-threatening infections.
Public health officials are urging pregnant and breastfeeding moms to get the COVID-19 vaccine – and soon.
In June of this year, at age two, my daughter, Aria, was sent home from daycare with a high fever. Her pediatrician was concerned and prescribed an antibiotic for a bacterial pneumonia. A COVID-19 swab was obtained – negative. Yet after a few days, she still wasn’t getting better. In fact, she was getting worse.
Among the world’s developed countries, the United States holds the unwanted distinction of being a leader in maternal and infant deaths. In an attempt to turn the tide, the federal government last month announced a new $350 million investment.
Maternal vaccines can protect pregnant moms and vulnerable babies. So why aren’t more women getting them?
I am a neonatologist by training, a “neo-gadgetologist” by passion. I love testing out device prototypes and integrating new technologies at the hospital where I practice. I get excited by their potential to improve care for the infants we treat.